{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:20:10Z","timestamp":1767093610802,"version":"3.44.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejphar.2020.173743","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T16:51:55Z","timestamp":1605718315000},"page":"173743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Influence of purinergic signaling on glucose transporters: A possible mechanism against insulin resistance?"],"prefix":"10.1016","volume":"892","author":[{"given":"Guilherme Pegas","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson Xavier","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173743_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2019.08.004","article-title":"Toxicity of metformin and hypoglycemic therapies","volume":"27","author":"Akhter","year":"2020","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.ejphar.2020.173743_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2125.2012.04320.x","article-title":"Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects","volume":"75","author":"Ali","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173743_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1464-5491.2001.00445.x","article-title":"Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus","volume":"18","author":"Ambrosch","year":"2001","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejphar.2020.173743_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1573399811309030004","article-title":"Modulation of P2 receptors on pancreatic \u03b2-cells by agonists and antagonists: a molecular target for type 2 diabetes treatment","volume":"9","author":"Anastacio Furtado Pacheco","year":"2013","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.ejphar.2020.173743_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2015.10","article-title":"Adenosine signalling in diabetes mellitus-pathophysiology and therapeutic considerations","volume":"11","author":"Antonioli","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.173743_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"18","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173743_bib7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1242\/jcs.02865","article-title":"Extracellular adenosine activates AMP-dependent protein kinase (AMPK)","volume":"119","author":"Aymerich","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116203","article-title":"Enhancement of glucose uptake in mouse skeletal muscle cells and adipocytes by P2Y6 receptor agonists","volume":"9","author":"Balasubramanian","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173743_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-007-0038-8","article-title":"Molecular mechanism of insulin resistance","volume":"32","author":"Bhattacharya","year":"2007","journal-title":"J. Biosci."},{"key":"10.1016\/j.ejphar.2020.173743_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","article-title":"HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study","volume":"25","author":"Bonora","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2020.173743_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jcp.24111","article-title":"Glucose transporter 2 expression is down regulated following P2X7 activation in enterocytes","volume":"228","author":"Bourzac","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2020.173743_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1005632012591","article-title":"Glucose transporters: structure, function and consequences of deficiency","volume":"23","author":"Brown","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejphar.2020.173743_bib13","doi-asserted-by":"crossref","first-page":"14523","DOI":"10.1016\/S0021-9258(18)42067-4","article-title":"Fructose transporter in human spermatozoa and small intestine is GLUTS","volume":"267","author":"Burant","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173743_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/13813455.2012.755547","article-title":"Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice","volume":"119","author":"Burghoff","year":"2013","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2020.173743_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2398212818817494","article-title":"Purine and purinergic receptors","volume":"2","author":"Burnstock","year":"2018","journal-title":"Brain Neurosci. Adv."},{"key":"10.1016\/j.ejphar.2020.173743_bib16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00018-007-6497-0","article-title":"Purine and pyrimidine receptors","volume":"64","author":"Burnstock","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2020.173743_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ejphar.2020.173743_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11302-013-9359-2","article-title":"Purinergic signalling and diabetes","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejphar.2020.173743_bib20","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1073\/pnas.97.13.7313","article-title":"GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst","volume":"97","author":"Carayannopoulos","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173743_bib21","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90394.2008","article-title":"GLUT7: a new intestinal facilitated hexose transporter","volume":"295","author":"Cheeseman","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173743_bib22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.biocel.2013.02.009","article-title":"ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy","volume":"45","author":"Chen","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173743_bib23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/db13-0573","article-title":"A2B Adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation","volume":"63","author":"Cs\u00f3ka","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173743_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2020.173743_bib25","first-page":"61","article-title":"The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies","volume":"8","author":"Davies","year":"2016","journal-title":"Clin. Pharmacol. Adv. Appl."},{"key":"10.1016\/j.ejphar.2020.173743_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","article-title":"Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity","volume":"61","author":"Deaglio","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173743_bib27","first-page":"142","article-title":"Free fatty acids and insulin resistance","volume":"10","author":"Delarue","year":"2007","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ejphar.2020.173743_bib28","doi-asserted-by":"crossref","first-page":"E831","DOI":"10.1152\/ajpendo.00296.2009","article-title":"Facilitative glucose transporter 9, a unique hexose and urate transporter","volume":"297","author":"Doblado","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173743_bib29","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173743_bib30","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/db07-1265","article-title":"Deletion of Cd39\/Entpd1 results in hepatic insulin resistance","volume":"57","author":"Enjyoji","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173743_bib31","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","article-title":"Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration","volume":"266","author":"Facchini","year":"1991","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2020.173743_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1074\/jbc.274.2.755","article-title":"Purinergic inhibition of glucose transport in cardiomyocytes","volume":"274","author":"Fischer","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173743_bib33","first-page":"139","article-title":"Resist\u00eancia \u00e0 Insulina Associada \u00e0 Obesidade: efeitos Anti-Inflamat\u00f3rios do Exerc\u00edcio F\u00edsico","volume":"22","author":"Freitas","year":"2014","journal-title":"Rev. Bras. Ci\u00eancia Mov."},{"key":"10.1016\/j.ejphar.2020.173743_bib34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.ATV.16.8.1000","article-title":"Interleukin-1\u03b2 in coronary arteries of patients with ischemic heart disease","volume":"16","author":"Galea","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173743_bib35","doi-asserted-by":"crossref","first-page":"6S28","DOI":"10.1016\/S1262-3636(03)72785-2","article-title":"Reducing insulin resistance with metformin: the evidence today","volume":"29","author":"Giannarelli","year":"2003","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejphar.2020.173743_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.7150\/ijbs.11241","article-title":"Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus","volume":"11","author":"Hajiaghaalipour","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib37","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2337\/diabetes.47.11.1671","article-title":"Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions","volume":"47","author":"Han","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173743_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd2638","article-title":"Adenosine receptors: therapeutic aspects for inflammatory and immune diseases","volume":"7","author":"Hask\u00f3","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173743_bib39","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1042\/BCJ20170677","article-title":"Chemical biology probes of mammalian GLUT structure and function","volume":"475","author":"Holman","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2020.173743_bib40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2013-09-402560","article-title":"Extracellular nucleotide and nucleoside signaling in vascular and blood disease","volume":"124","author":"Idzko","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2020.173743_bib41","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jmb.2019.08.014","article-title":"Ion channels of the islets in type 2 diabetes","volume":"432","author":"Jacobson","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2020.173743_bib42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1126\/science.2237405","article-title":"Underexpression of \u03b2 cell high Km glucose transporters in noninsulin-dependent diabetes","volume":"250","author":"Johnson","year":"1990","journal-title":"Science (80-. )"},{"key":"10.1016\/j.ejphar.2020.173743_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.56808\/3027-7922.2355","article-title":"The effect of glucose, adenosine-5\u2019-triphosphate, and adenosine on glucose transporter 9 expression in Madin-Darby Canine Kidney (MDCK) cells","volume":"43","author":"Kanchanapiboon","year":"2019","journal-title":"Thai J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib44","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbrc.2010.12.051","article-title":"Purinergic modulation of glucose uptake into cultured rat podocytes: effect of diabetic milieu","volume":"404","author":"Karczewska","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.173743_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms10555","article-title":"Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1\u03b2 secretion in response to ATP","volume":"7","author":"Karmakar","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173743_bib46","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2020.173743_bib47","first-page":"1","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173743_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mce.2013.09.011","article-title":"Activation of inflammasomes in adipose tissue of women with gestational diabetes","volume":"382","author":"Lappas","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.173743_bib49","doi-asserted-by":"crossref","first-page":"C1268","DOI":"10.1152\/ajpcell.00002.2005","article-title":"Effect of adenosine triphosphate on phosphate uptake in renal proximal tubule cells: involvement of PKC and p38 MAPK","volume":"289","author":"Lee","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2020.173743_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11302-005-6209-x","article-title":"The P2Y1 receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice","volume":"1","author":"L\u00e9on","year":"2005","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejphar.2020.173743_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0004-27301998000600003","article-title":"Transportadores de glicose","volume":"42","author":"Machado","year":"1998","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2020.173743_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0004-27302006000200004","article-title":"Transportadores de glicose na s\u00edndrome metab\u00f3lica","volume":"50","author":"Machado","year":"2006","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2020.173743_bib53","article-title":"Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines","volume":"1\u201312","author":"Makki","year":"2013","journal-title":"ISRN Inflamm"},{"key":"10.1016\/j.ejphar.2020.173743_bib54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.2040-1124.2011.00177.x","article-title":"GLUT12: a second insulin-responsive glucose transporters as an emerging target for type 2 diabetes","volume":"3","author":"Matsuzaka","year":"2012","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.ejphar.2020.173743_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dom.12169","article-title":"NLRP3 and IL-1\u03b2 in macrophages as critical regulators of metabolic diseases","volume":"3","author":"Mcgettrick","year":"2013","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2020.173743_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4067\/S0716-97602002000100004","article-title":"Glucose transporters: expression, regulation and cancer","volume":"35","author":"Medina","year":"2002","journal-title":"Biol. Res."},{"key":"10.1016\/j.ejphar.2020.173743_bib57","series-title":"Advances in Anatomy Embryology and Cell Biology","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-540-78899-7_7","article-title":"Molecular diversity of facilitative glucose transporters in articular chondrocytes","author":"Mobasheri","year":"2008"},{"key":"10.1016\/j.ejphar.2020.173743_bib58","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1432-1033.1994.tb18550.x","article-title":"Facilitative glucose transporters","volume":"219","author":"Mueckler","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejphar.2020.173743_bib59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1126\/science.3839598","article-title":"Sequence and structure of a human glucose transporter","volume":"229","author":"Mueckler","year":"1985","journal-title":"Science (80-. )"},{"key":"10.1016\/j.ejphar.2020.173743_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2020.173743_bib61","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2337\/diabetes.50.5.921","article-title":"AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise","volume":"50","author":"Musi","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173743_bib62","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173743_bib63","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1098\/rstb.2015.0427","article-title":"P2X receptors","volume":"371","author":"North","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2018.02.002","article-title":"P2X receptor-ion channels in the inflammatory response in adipose tissue and pancreas \u2014 potential triggers in onset of type 2 diabetes?","volume":"52","author":"Novak","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2020.173743_bib65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1590\/S0004-27302009000400003","article-title":"Novos mecanismos pelos quais o exerc\u00edcio f\u00edsico melhora a resist\u00eancia \u00e0 insulina no m\u00fasculo esquel\u00e9tico","volume":"53","author":"Pauli","year":"2009","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2020.173743_bib66","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/sj.bjp.0702214","article-title":"Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell","volume":"125","author":"Petit","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173743_bib67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1098-2299(199611\/12)39:3\/4<413::AID-DDR23>3.0.CO;2-0","article-title":"Purinergic receptors and metabolic function","volume":"39","author":"Petit","year":"1996","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2020.173743_bib68","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173743_bib69","first-page":"607","article-title":"Metformin reduces NAD(P)H oxidase activity in mouse cultured podocytes through purinergic dependent mechanism by increasing extracellular ATP concentration","volume":"60","author":"Piwkowska","year":"2013","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejphar.2020.173743_bib70","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/db11-0033","article-title":"Improved insulin sensitivity by GLUT12 overexpression in mice","volume":"60","author":"Purcell","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173743_bib71","series-title":"Pharmacological Reviews","first-page":"413","article-title":"Receptors for purines and pyrimidines","author":"Ralevic","year":"1998"},{"key":"10.1016\/j.ejphar.2020.173743_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1358\/dnp.2003.16.3.876886","article-title":"Involvement of purinergic signaling in cardiovascular diseases","volume":"16","author":"Ralevic","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ejphar.2020.173743_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-nutr-071816-064836","article-title":"Fatty acids and NLRP3 inflammasome\u2013mediated inflammation in metabolic tissues","volume":"37","author":"Ralston","year":"2017","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ejphar.2020.173743_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4239\/wjd.v1.i3.68","article-title":"Molecular mechanisms of insulin resistance in type 2 diabetes mellitus","volume":"1","author":"Saini","year":"2010","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejphar.2020.173743_bib75","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/09687860500166143","article-title":"Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue","volume":"22","author":"Scheepers","year":"2005","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.ejphar.2020.173743_bib76","first-page":"1","article-title":"TLR4 and insulin resistance","author":"Sears","year":"2010","journal-title":"Gastroenterol. Res. Pract"},{"key":"10.1016\/j.ejphar.2020.173743_bib77","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173743_bib78","first-page":"48","article-title":"PROCESSOS inflamat\u00f3rios da obesidade","volume":"12","author":"Sippel","year":"2015","journal-title":"Rev. Bras. Ci\u00eancias da Sa\u00fade - USCS"},{"key":"10.1016\/j.ejphar.2020.173743_bib79","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jcp.10379","article-title":"Defective P2Y purinergic receptor function: a possible novel mechanism for impaired glucose transport","volume":"197","author":"Solini","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2020.173743_bib80","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.celrep.2017.01.047","article-title":"Inhibition of P2Y6 signaling in AgRP neurons reduces food intake and improves systemic insulin sensitivity in obesity","volume":"18","author":"Steculorum","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2020.173743_bib81","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2020.173743_bib82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0003-9861(02)00056-5","article-title":"ATP stimulates glucose transport through activation of P2 purinergic receptors in C2C12 skeletal muscle cells","volume":"401","author":"Suk Kim","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2020.173743_bib83","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00018-009-0191-3","article-title":"ADP receptor P2Y13 induce apoptosis in pancreatic \u03b2-cells","volume":"67","author":"Tan","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib84","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173743_bib85","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1139\/H07-039","article-title":"Activation of the A1 adenosine receptor increases insulin-stimulated glucose transport in isolated rat soleus muscle","volume":"32","author":"Thong","year":"2007","journal-title":"Appl. Physiol. Nutr. Metabol."},{"key":"10.1016\/j.ejphar.2020.173743_bib86","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","article-title":"Glucose transporters in the 21st century","volume":"298","author":"Thorens","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173743_bib87","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.3748\/wjg.v21.i39.10931","article-title":"Anticancer effect of adenosine on gastric cancer via diverse signaling pathways","volume":"21","author":"Tsuchiya","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2020.173743_bib88","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/wmts.61","article-title":"P2Y receptors and kidney function","volume":"1","author":"Vallon","year":"2012","journal-title":"Wiley Interdiscip. Rev. Membr. Transp. Signal."},{"key":"10.1016\/j.ejphar.2020.173743_bib89","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1167\/iovs.11-8997","article-title":"Early neurodegeneration in the retina of type 2 diabetic patients","volume":"53","author":"van Dijk","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib90","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2019.00507","article-title":"Ectonucleotidases in intestinal and hepatic inflammation","volume":"10","author":"Vuerich","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2020.173743_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-020-00388-1","article-title":"P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2020.173743_bib92","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1242\/jcs.034355","article-title":"Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins","volume":"122","author":"Wang","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2020.173743_bib93","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fendo.2020.00341","article-title":"P2Y(2) receptor promotes high-fat diet-induced obesity","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.ejphar.2020.173743_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.02.004","article-title":"Alteration of purinergic signaling in diabetes: focus on vascular function","volume":"140","author":"Zhou","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173743_bib95","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/JPER.18-0528","article-title":"Metformin ameliorates experimental diabetic periodontitis independently of mammalian target of rapamycin (mTOR) inhibition by reducing NIMA-related kinase 7(Nek7) expression","volume":"90","author":"Zhou","year":"2019","journal-title":"J. Periodontol."},{"key":"10.1016\/j.ejphar.2020.173743_bib96","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0301-0082(96)00026-3","article-title":"Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system","volume":"49","author":"Zimmermann","year":"1996","journal-title":"Prog. Neurobiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:48:25Z","timestamp":1757976505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920308359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":96,"alternative-id":["S0014299920308359"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173743","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of purinergic signaling on glucose transporters: A possible mechanism against insulin resistance?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173743"}}